Recently, a meta-analysis found that combining radiotherapy and chemotherapy with PD-1/PD-L1 inhibitors increases the incidence of Grades 1–2 immune-related pneumonitis or radiation pneumonitis but does not increase Grade ≥ 3 pneumonitis incidence [23]. The gene discussed is CD274; the disease is pneumonitis.